Cardiac Dimensions
We’re reimagining solutions for patients suffering from heart failure by treating the underlying causes, not just the symptoms, with Carillon therapy.
$53M Series B+ ·
Led by Ally Bridge Group · Source: fundraisingfox.com
Total raised: $149.2M across 6 sourced rounds
All 7 rounds ↓Signals
Cardiac Dimensions | 4597 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $53M | fundraisingfox.com | ||
| Series B+ | $35M | biospace.com | ||
| Series B+ | $17.5M | — | finsmes.com | |
| Series B+ | undisclosed | businesswire.com | ||
| Series A | $15.2M | — | pehub.com | |
| Series A | $8.5M | pehub.com | ||
| Series A | $20M | pevc.dowjones.com |
Timeline
- X account created
- Website created
Founders and team
MM
Mark Mathis FounderMM
Matt McNamara Non Executive Director- BCBob Calcote Vice President, Operations
- BCBob Conta Vice Pres. R.&D.
RW
Rick Wypych President and Chief Executive OfficerSS
Satya Shreenivas Chief Medical Officer- SGSteven Goldberg Chief Clinical Officer
WA
William Abraham Chief Medical Officer
Investors
AAlly Bridge Grouplead investor
AAperture Venture Partners
AArboretum Ventureslead investor
CClaret Capital Partners
DDifference CapitalEEQT Life Sciences
HHorizon 3lead investor
HHorizon 3 Healthcare
HHostpluslead investor
- LLSP Health Economics Fund
LLumira Ventureslead investor
MM. H. Carnegie & Co.lead investor
OOxford Finance LLCRRedbus Ventures
Companies like Cardiac Dimensions
AAxon Therapies$32M · Sep 2025
RRestore Medical$23M Series B+ · Jul 2025
CCeryx Medical$5M Seed · May 2022NNuevocor$45M Series B+ · May 2025
FFreya BiosciencesSeries A · Nov 2024
SSama TherapeuticsSeed
Other companies backed by Ally Bridge Group
CCMR Surgical$400M Series B+ · Oct 2026
EEpicrispr Biotechnologies$90M Series B+ · Aug 2026
AAdvanCell$315M Series B+ · Jul 2026
VVida Health$4M Series A · Nov 2025
TTranscarent$126M Series B+ · May 2024
AAlzheon$100M Series B+ · Apr 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cardiac-dimensions (get a free API key).